Výsledky vyhledávání - "Haibel, Hiltrun"

Treatment response to biological disease-modifying anti-rheumatic drugs is associated with favorable changes of the body composition in patients with ankylosing spondylitis

Autor: Rios Rodriguez, Valeria, Protopopov, Mikhail, Proft, Fabian, Rademacher, Judith, Muche, Burkhard, Weber, Anne Katrin, Lüders, Susanne, Haibel, Hiltrun, Verba, Maryna, Sieper, Joachim, Poddubnyy, Denis

Publikováno v: Deutscher Rheumatologiekongress 2020, 48. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 34. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh); 20200909-20200912; sine loco [digital]; DOCSpA.32 /20200909/

Introduction: There is few data available regarding differences in body composition and its possible changes in patients with ankylosing spondylitis (AS) treated with biological disease-modifying anti-rheumatic drugs (bDMARDs). Objectives: To evaluat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::985ab383b99ba560c13eb8dd81ac3fce
http://nbn-resolving.de/urn:nbn:de:0183-20dgrh1524

Zobrazit plný text záznamu

Impact of body composition measures on the response to biological disease-modifying anti-rheumatic drugs in patients with ankylosing spondylitis

Introduction: Data on the impact of different components of the body composition (BC) on the response to biological disease-modifying anti-rheumatic drugs (bDMARDs) are lacking. Objectives: To investigate the impact of BC on the response to biologica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c562d12e775cbbcd1dfb67e3a5adf96
http://www.egms.de/en/meetings/dgrh2020/20dgrh153.shtml

Zobrazit plný text záznamu

Long-Term Clinical Outcome Of Anti-Tnf Treatment In Patients With Early Axial Spondyloarthritis: 10-Year Data Of The Etanercept Vs. Sulfasalazin In Early Axial Spondyloarthritis Trial

Autor: Proft, Fabian, Torgutalp, Murat, Weiß, Anja, Protopopov, Mikhail, Rios Rodriguez, Valeria, Haibel, Hiltrun, Behmer, Olaf, Sieper, Joachim, Poddubnyy, Denis

Introduction: Long-term data on anti-TNF treatment in patients with early axial spondyloarthritis (SpA) is scarce. The objective of this analysis was to assess the long-term clinical efficacy (up to 10 years of treatment) of a tumor necrosis factor (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c73b0659aba08ad03968851369de05d
https://aperta.ulakbim.gov.tr/record/68259

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání